Clinical Trial: A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548853) titled 'A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis' on April 16.

Brief Summary: An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Hyperphosphatemia Patients on Peritoneal Dialysis

Intervention: DRUG: 'TS-172 20~60 mg/day

oral administration of TS-172 20~60 mg/day

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Taisho Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....